Skip to main content
66°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly And Co
Recent news which mentions Eli Lilly And Co
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Jim Cramer's top picks for pet-centric stocks
June 25, 2024
Tags
Stock markets
Business
Chewy Inc
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
US Top News and Analysis
China Economy
Asia: Top News and Analysis
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Business News
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024
Tags
Science
Eli Lilly and Co
US: News
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Zealand Pharma A/S
Eli Lilly and Co
Europe Markets
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Health & Science
Social issues
Healthy Returns
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Health care industry
Companies
Alphabet Inc
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Business
Stock markets
Eisai Co Ltd
From
CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
June 10, 2024
Tags
Business News
Pharmaceuticals
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
June 07, 2024
Tickers
RH
Tags
Signet Jewelers Ltd
Affirm Holdings Inc
Stock Picks
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Science
Bristol/Myers Squibb Co
Eli Lilly and Co
From
CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
June 06, 2024
Tags
Alphabet Inc
Breaking News: Technology
Eli Lilly and Co
From
CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
June 05, 2024
Tags
Alphabet Inc
Technology
Breaking News: Technology
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Small Business Playbook
Social issues
Small business
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Business News
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Personal investing
stocks
AI / Artificial Intelligence
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
WW International Inc
Hims & Hers Health Inc
Mobile
From
CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
May 24, 2024
Tags
Companies
Biotechnology
Business
From
CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
May 23, 2024
Tags
S&P 500
Investing
Eli Lilly and Co
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Fusion Pharmaceuticals Inc
Health & Science
Investing
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Uber Technologies Inc
Science
Eli Lilly and Co
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
US: News
Eli Lilly and Co
Business
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Healthy Returns
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Business News
Biotech and Pharmaceuticals
Pharmaceuticals
From
CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
May 13, 2024
Tags
Technology
AI / Artificial Intelligence
Alphabet Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Apple Inc
Health & Science
Healthy Returns
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Science
Altimmune Inc
US: News
From
CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
May 05, 2024
Tags
AI / Artificial Intelligence
Drugs
Drug trials
From
CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
May 03, 2024
Tags
Companies
Amgen Inc
Health care industry
From
CNBC.com News
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
May 03, 2024
Tags
Biotech and Pharmaceuticals
Pharmaceuticals
Europe News
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.